Filings & corporate actions
44 results filed
CSVNext results · Q2 FY27
Expected 18 Oct 2026 – 5 Nov 2026
Estimate: filed 18–36 days after quarter end, last 5 times
Dividend
₹1.25 per share · last 25 Jun 2026
2026
- 29 JulresultsResults · Q1 FY27 · consolidated and standalone-3.6%NSE
- 17 JulshareholdingShareholding · 30 Jun 2026-0.5%NSE
- 25 JundividendDividend · ₹1.25 per share-1.5%
- 29 AprresultsResults · Q4 FY26 · consolidated and standalone+8.2%NSE
- 17 AprshareholdingShareholding · 31 Mar 2026+0.4%NSE
- 22 JanresultsResults · Q3 FY26 · consolidated and standalone-8.2%NSE
- 18 JanshareholdingShareholding · 31 Dec 2025-0.3%NSE
Reaction to results · all yearsrose on day 0 in 15 of 44 CSV
| Quarter | Filed | Day 0 | +5D | +20D | Rel vol |
|---|---|---|---|---|---|
| Q1 FY27 | 29 Jul 2026 | -3.6% | -3.5% | -0.1% | 16.2× |
| Q4 FY26 | 29 Apr 2026 | +8.2% | +6.0% | +3.7% | 54.1× |
| Q3 FY26 | 22 Jan 2026 | -8.2% | -21.5% | -25.3% | 6.8× |
| Q2 FY26 | 5 Nov 2025 | -4.0% | +2.4% | -0.6% | 3.0× |
| Q1 FY26 | 23 Jul 2025 | -1.6% | +4.9% | -2.0% | 1.8× |
| Q4 FY25 | 24 Apr 2025 | -12.8% | -16.2% | -14.9% | 31.0× |
| Q3 FY25 | 23 Jan 2025 | -6.0% | -11.8% | -15.6% | 7.4× |
| Q2 FY25 | 23 Oct 2024 | +5.1% | +2.8% | +7.0% | 5.2× |
| Q1 FY25 | 25 Jul 2024 | +5.5% | +11.1% | +13.0% | 3.3× |
| Q4 FY24 | 25 Apr 2024 | -0.1% | -3.7% | -4.4% | 1.3× |
| Q3 FY24 | 26 Jan 2024 | -0.3% | +8.2% | +6.6% | 2.1× |
| Q2 FY24 | 18 Oct 2023 | -2.0% | -6.2% | +1.0% | 2.3× |
| Q1 FY24 | 26 Jul 2023 | +5.9% | +4.8% | +0.5% | 8.3× |
| Q4 FY23 | 27 Apr 2023 | +4.2% | +7.4% | +9.9% | 4.4× |
| Q3 FY23 | 24 Jan 2023 | -1.6% | -3.2% | +0.6% | 1.0× |
| Q2 FY23 | 20 Oct 2022 | -1.6% | +4.1% | +1.9% | 1.7× |
| Q4 FY22 | 28 Apr 2022 | +1.1% | -5.1% | -9.4% | 1.8× |
| Q3 FY22 | 20 Jan 2022 | -1.7% | -6.2% | -9.9% | 0.8× |
| Q2 FY22 | 21 Oct 2021 | -2.9% | -9.2% | -1.8% | 1.4× |
| Q1 FY22 | 21 Jul 2021 | -3.6% | -4.0% | -4.0% | 1.5× |
| Q4 FY21 | 28 Apr 2021 | -5.4% | -3.4% | -3.3% | 2.3× |
| Q3 FY21 | 21 Jan 2021 | -4.1% | -7.9% | -8.9% | 1.2× |
| Q2 FY21 | 22 Oct 2020 | -2.9% | -2.5% | +3.7% | 2.2× |
| Q1 FY21 | 21 Jul 2020 | -1.3% | +7.5% | +14.3% | 0.5× |
| Q4 FY20 | 13 May 2020 | +2.0% | +9.5% | +13.9% | 1.2× |
| Q3 FY20 | 23 Jan 2020 | -1.6% | -0.1% | -1.0% | 2.6× |
| Q2 FY20 | 22 Oct 2019 | +1.3% | +1.4% | -0.2% | 1.6× |
| Q1 FY20 | 25 Jul 2019 | +0.7% | -3.0% | -2.6% | 0.2× |
| Q4 FY19 | 24 May 2019 | +3.3% | +9.7% | +4.4% | 0.8× |
| Q3 FY19 | 24 Jan 2019 | +1.6% | -0.2% | +1.4% | 7.4× |
| Q2 FY19 | 30 Oct 2018 | -2.6% | -0.1% | -7.4% | 1.6× |
| Q1 FY19 | 7 Aug 2018 | -0.1% | -0.5% | +6.3% | 5.1× |
| Q4 FY18 | 2 Jul 2018 | -2.6% | -2.0% | -2.5% | 0.4× |
| Q3 FY18 | 10 Feb 2018 | +1.7% | +0.6% | -3.7% | 0.3× |
| Q2 FY18 | 30 Oct 2017 | +1.3% | +0.1% | +3.6% | 0.5× |
| Q1 FY18 | 1 Aug 2017 | -2.0% | -2.0% | -6.0% | 0.6× |
| Q4 FY17 | 16 Jun 2017 | -0.2% | +0.3% | +9.0% | 0.5× |
| Q3 FY17 | 27 Jan 2017 | -0.7% | -5.8% | -10.6% | 5.4× |
| Q2 FY17 | 20 Oct 2016 | +1.0% | +7.9% | -3.7% | 4.5× |
| Q1 FY17 | 27 Sept 2016 | -2.2% | -3.3% | +7.9% | 0.5× |
| Q1 FY16 | 27 Sept 2016 | -2.2% | -3.3% | +7.9% | 0.5× |
| Q4 FY16 | 29 Apr 2016 | -0.6% | -4.9% | -1.4% | 0.8× |
| Q3 FY16 | 29 Apr 2016 | -0.6% | -4.9% | -1.4% | 0.8× |
| Q2 FY16 | 23 Oct 2015 | +0.1% | -3.0% | -2.6% | 0.6× |
| Average | -0.8% | -1.1% | -0.6% | ||
Close-to-close from the session before the filing could trade. Day 0 is the first session after it.
Growth · Q1 FY27
CSVRevenue YoY-15.8%
Profit YoY-110.4%
Interest cost YoY-11.7%
Revenue QoQ-29.0%
Profit QoQ-106.1%
| CAGR | 2Y | 3Y | 4Y | 5Y | 6Y | 7Y |
|---|---|---|---|---|---|---|
| Revenue | +1.9% | +2.4% | — | +8.8% | +10.2% | — |
| Profit | -33.0% | -23.0% | — | -12.2% | -9.3% | — |
Key data
CSVOpen357.40
Day range355.55 – 364.00
52-week range353.30 – 678.95
From 52w high-46.5%
RSI (14)35.6
ATR (14)9.98
Volume3.19L
Avg volume (20D)6.15L
Rel volume0.52×
Volatility (1Y)32.2%
Turnover₹11.6Cr
SMA 50 / 200392.73 / 453.22
Delivery percentage
Latest · 6 Oct 202660.0%
20-day avg53.2%
1-year avg51.6%
Percentile (own history)72nd
Range9.4–95.9%
Sessions1,731
Over the last 20 sessions SYNGENE settled 53.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 51.6%. The latest session ranks higher than 72% of the 1,731 sessions on record for it.
What delivery percentage measuresScan the whole market on delivery
IndustryHealthcare Research Analytics & Technology
Performance returns
CSV| 1D | 1W | 1M | 3M | 6M | 1Y | |
|---|---|---|---|---|---|---|
| Price | +1.62% | -3.40% | -9.38% | -14.08% | -7.13% | -40.41% |
Valuation
CSVMarket cap₹14,661 Cr
P/E (TTM)66.3
EPS (TTM)5.47
Shares outstanding40.37Cr
Listed11 Aug 2015
Ownership
CSVPromoter52.59%
Promoter Δ QoQ-0.09 pp
Public46.98%
FII11.82%
DII28.02%
Pledged0.00%
Quarterly results · consolidated
CSV| Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|
| Revenue (₹ Cr) | 910.6 | 917.1 | 1,036.5 | 736.0 |
| YoY chg | +2.2% | -2.8% | +1.8% | -15.8% |
| Net profit (₹ Cr) | 67.1 | 15.0 | 147.9 | (9.0) |
| YoY chg | -36.8% | -88.6% | -19.3% | -110.4% |
| Net margin | 7.4% | 1.6% | 14.3% | -1.2% |
| EPS | 1.67 | 0.37 | 3.67 | -0.22 |
Shareholding over time
CSVBy quarter
30 Jun 2026 · promoter 52.59% · public 46.98%2021-092026-06
- Promoter
- Public and others
- Promoter
- 52.59%
- Public
- 46.98%
- Promoter change
- -0.09 pp
- Filed
- 17 Jul 2026
- FII
- 11.82%
- DII
- 28.02%
- Promoter pledged
- 0.00%
Promoter and public shares of total equity, from the pattern filed each quarter. Institutional and pledge figures come from a separate filing stage whose backfill is still running, so they are absent for almost every instrument rather than zero.
Financials · quarterly statement
CSV₹ crore, as filed
| Q2 FY24 | Q3 FY24 | Q4 FY24A | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25A | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26A | Q1 FY27 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue from operations | 910.1 | 853.5 | 916.9 | 789.7 | 891.0 | 943.7 | 1,018.0 | 874.5 | 910.6 | 917.1 | 1,036.5 | 736.0 | |
| Other income | 21.6 | 29.3 | 16.1 | 18.1 | 16.5 | 18.3 | 18.9 | 17.7 | 15.4 | 15.4 | 22.2 | 25.3 | |
| Total income | 931.7 | 882.8 | 933.0 | 807.8 | 907.5 | 962.0 | 1,036.9 | 892.2 | 926.0 | 932.5 | 1,058.7 | 761.3 | |
| Total expenses | 773.6 | 740.9 | 724.0 | 738.5 | 770.2 | 781.2 | 796.4 | 790.9 | 840.8 | 833.5 | 856.7 | 767.0 | |
| └ Finance costs | 13.0 | 10.8 | 12.9 | 11.7 | 13.1 | 12.4 | 15.9 | 11.6 | 13.2 | 11.9 | 12.1 | 9.6 | |
| └ Depreciation | 104.6 | 108.1 | 111.1 | 106.9 | 110.9 | 108.7 | 106.1 | 111.2 | 116.5 | 113.7 | 111.5 | 112.2 | |
| Profit before tax | 150.7 | 138.2 | 209.0 | 101.3 | 137.3 | 180.8 | 240.5 | 101.3 | 85.2 | 28.4 | 196.0 | (19.2) | |
| Tax expense | 34.2 | 26.7 | 20.4 | 25.6 | 31.2 | 49.7 | 57.2 | 14.6 | 18.1 | 13.4 | 48.1 | (10.2) | |
| Net profit | 116.5 | 111.5 | 188.6 | 75.7 | 106.1 | 131.1 | 183.3 | 86.7 | 67.1 | 15.0 | 147.9 | (9.0) | |
| EPS | 2.90 | 2.78 | 4.70 | 1.89 | 2.64 | 3.27 | 4.56 | 2.16 | 1.67 | 0.37 | 3.68 | -0.22 | |
| Net margin | 12.80% | 13.06% | 20.57% | 9.59% | 11.91% | 13.89% | 18.01% | 9.91% | 7.37% | 1.64% | 14.27% | -1.22% | |
| PBT margin | 16.56% | 16.19% | 22.79% | 12.83% | 15.41% | 19.16% | 23.62% | 11.58% | 9.36% | 3.10% | 18.91% | -2.61% | |
| Tax rate | 22.69% | 19.32% | 9.76% | 25.27% | 22.72% | 27.49% | 23.78% | 14.41% | 21.24% | 47.18% | 24.54% | — |
A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. A quarterly filing carries a profit and loss only — there is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure here. Latest filed 29 Jul 2026.
SYNGENE at a glance
- SYNGENE closed at ₹363.2 on 6 Oct 2026, +1.62% on the day, -40.4% over one year, 46.5% below its 52-week high of ₹678.95.
- Delivery was 60.0% of traded quantity on 6 Oct 2026, the 72nd percentile of its own 1,731 sessions with a reading (20-session average 53.2%, 1-year average 51.6%).
- Market capitalisation is ₹14,661 crore at a trailing P/E of 66.3 (trailing EPS ₹5.47).
- Q1 FY27 results (consolidated, filed 29 Jul 2026): revenue ₹736 crore (-15.8% year on year), net profit ₹-9 crore (-110.4%); the price moved -3.6% on the first session after.
- Promoters held 52.59% at 30 Jun 2026, down 0.09 percentage points on the previous filing.
- Q2 FY27 results are expected between 18 Oct 2026 and 5 Nov 2026, going by past filing dates — an estimate, not an announcement.
About
CSVMacro sectorHealthcare
Basic industryHealthcare Research Analytics & Technology
ISININE398R01022
SeriesEQ
Listed11 Aug 2015
History from11 Aug 2015
Sessions2,758
Turnover rank#720
Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 6 Oct 2026.
More in Healthcare Services
CSV- APOLLOHOSPApollo Hospitals Enterprise Limited7,914.50-0.88%
- MAXHEALTHMax Healthcare Institute Limited902.50-1.58%
- FORTISFortis Healthcare Limited764.00+0.03%
- YATHARTHYatharth Hospital & Trauma Care Services Limited1,058.80+5.56%
- ASTERDMAster DM Quality Care Limited684.70-0.98%
- MANIPALHOSManipal Health Enterprises Limited690.50+3.52%
- LALPATHLABDr. Lal Path Labs Ltd.1,964.20-0.36%
- ARTEMISMEDArtemis Medicare Services Limited318.35-1.77%
- NEPHROPLUSNephrocare Health Services Limited634.55-0.49%
- GKSLGujarat Kidney And Super Speciality Limited193.62+1.72%
- KIMSKrishna Institute of Medical Sciences Limited693.40-1.71%
- NHNarayana Hrudayalaya Ltd.1,723.80+0.08%
All Healthcare Services stocks on the NSEAll Healthcare stocks on the NSE